nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A voice for the silent
|
Thorley, Jennifer |
|
2016 |
4 |
2 |
p. 100- 1 p. |
artikel |
2 |
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
|
Evans, Jonathan D W |
|
2016 |
4 |
2 |
p. 129-137 9 p. |
artikel |
3 |
BMPR2 revisited: are bigger data better?
|
Mazurek, Jeremy A |
|
2016 |
4 |
2 |
p. 87-89 3 p. |
artikel |
4 |
Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease
|
MacDonald, Martin I |
|
2016 |
4 |
2 |
p. 138-148 11 p. |
artikel |
5 |
Cardiac effects of current treatments of chronic obstructive pulmonary disease
|
Lahousse, Lies |
|
2016 |
4 |
2 |
p. 149-164 16 p. |
artikel |
6 |
CFTR modulation for young children with cystic fibrosis
|
Yammine, Sophie |
|
2016 |
4 |
2 |
p. 84-85 2 p. |
artikel |
7 |
Chronic pulmonary aspergillosis: help is on the way
|
The Lancet Respiratory Medicine, |
|
2016 |
4 |
2 |
p. 83- 1 p. |
artikel |
8 |
Cystic fibrosis: a call for research papers
|
Grainger, Emma |
|
2016 |
4 |
2 |
p. 95- 1 p. |
artikel |
9 |
E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis
|
Kalkhoran, Sara |
|
2016 |
4 |
2 |
p. 116-128 13 p. |
artikel |
10 |
Electronic cigarettes: more light, less heat needed
|
Bernstein, Steven L |
|
2016 |
4 |
2 |
p. 85-87 3 p. |
artikel |
11 |
Hitting home with technology development for asthma
|
Castner, Jessica |
|
2016 |
4 |
2 |
p. 102-103 2 p. |
artikel |
12 |
How the power of singing is helping patients to breathe again
|
Tanday, Sanjay |
|
2016 |
4 |
2 |
p. 101- 1 p. |
artikel |
13 |
Integrated Care Pathways for Airway Diseases
|
Stanley, Diana |
|
2016 |
4 |
2 |
p. 106- 1 p. |
artikel |
14 |
Knowledge gaps in therapeutic and non-therapeutic research on the Middle East respiratory syndrome
|
Arabi, Yaseen M |
|
2016 |
4 |
2 |
p. 93-94 2 p. |
artikel |
15 |
More targeted tuberculosis screening for immigrants?
|
Furlow, Bryant |
|
2016 |
4 |
2 |
p. 104-105 2 p. |
artikel |
16 |
NSAIDs versus opioids and chest tube size in pleurodesis
|
Burki, Talha Khan |
|
2016 |
4 |
2 |
p. 97- 1 p. |
artikel |
17 |
Of mice and men—the curious tale of β blockers in asthma
|
Lipworth, Brian |
|
2016 |
4 |
2 |
p. 89-91 3 p. |
artikel |
18 |
Prevalence of sleep apnoea syndrome in the middle to old age general population
|
Heinzer, Raphael |
|
2016 |
4 |
2 |
p. e5-e6 nvt p. |
artikel |
19 |
Progress with endobronchial valves for severe emphysema
|
Harding, Emilia |
|
2016 |
4 |
2 |
p. 97- 1 p. |
artikel |
20 |
Respiratory health in Poland
|
Sansom, Clare |
|
2016 |
4 |
2 |
p. 98-99 2 p. |
artikel |
21 |
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study
|
Davies, Jane C |
|
2016 |
4 |
2 |
p. 107-115 9 p. |
artikel |
22 |
Simple versus complex COPD: implications for health-care management
|
Agusti, Alvar |
|
2016 |
4 |
2 |
p. e6-e7 nvt p. |
artikel |
23 |
Take a deep breath in
|
Wilton, Jayne |
|
2016 |
4 |
2 |
p. 106- 1 p. |
artikel |
24 |
Treatment of cystic fibrosis in low-income countries
|
Cohen-Cymberknoh, Malena |
|
2016 |
4 |
2 |
p. 91-92 2 p. |
artikel |
25 |
What will COP21 mean for global respiratory health?
|
Burki, Talha Khan |
|
2016 |
4 |
2 |
p. 96- 1 p. |
artikel |